SCHEMBL2734307

SCHEMBL2734307

CC(C)(C)c1ccc(C(=O)OCC2CS2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
MAPT P10636 4/20 0.42
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HDAC1 Q13547 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.41
APEX1 P27695 1/20 0.41
RECQL P46063 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TNF P01375 1/20 0.40
KLF5 Q13887 1/20 0.40
NOD1 Q9Y239 1/20 0.40
BCHE P06276 2/20 0.40
SRD5A2 P31213 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2733345 0.81 CARM1 (0.45) CA1CA2MAPTTDP1L3MBTL1
SCHEMBL13498613 0.81 CARM1 (0.45) CA1CA2MAPTTDP1L3MBTL1
SCHEMBL1021591 0.79 TDP1 (0.52) TDP1L3MBTL1ALDH1A1MAPK1LMNA
SCHEMBL3240666 0.79 MAPT (0.45) CA1CA2MAPTTDP1L3MBTL1
SCHEMBL5456918 0.77 HDAC1 (0.52) CA1CA2MAPTTDP1L3MBTL1
SCHEMBL571045 0.75 CA12 (0.63) CA1CA2MAPTTDP1ALDH1A1
SCHEMBL2334169 0.74 CA1 (0.49) CA1CA2MAPTTDP1L3MBTL1
SCHEMBL14984037 0.74 TDP1 (0.58) CA1CA2MAPTTDP1L3MBTL1
SCHEMBL6063574 0.74 CA1 (0.49) CA1CA2MAPTTDP1L3MBTL1
SCHEMBL6896519 0.74 CA1 (0.53) CA1CA2MAPTTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431330-B2 Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent FUJIFILM CORPORATION (JP) 2013-04-30 US disclosed
US-8431330-B2 Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent FUJIFILM CORPORATION (JP) 2013-04-30 US disclosed
US-20120076991-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT FUJIFILM CORPORATION (JP) 2012-03-29 US disclosed
US-20120076991-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT FUJIFILM CORPORATION (JP) 2012-03-29 US disclosed
US-8088566-B2 Photoresists; using compound containing an orgaooxygen or organosulfur compound FUJIFILM CORPORATION (JP) 2012-01-03 US disclosed
US-8088566-B2 Photoresists; using compound containing an orgaooxygen or organosulfur compound FUJIFILM CORPORATION (JP) 2012-01-03 US disclosed
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
EP-1975718-A2 Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent FUJIFILM Corporation (JP) 2008-10-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT KRT18, FSCN1, SLC11A2 CA1 414/4885CA2 2469/4885MAPT 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.